The ProVIDe Study. The effect of higher intravenous protein intake for extremely low birthweight babies in the first week after birth on survival free from neurodevelopmental disability at 2 years' corrected age.

Not Applicable

Completed

• Conditions: Extremely preterm birth; Faltering growth / postnatal growth restriction; Neurodevelopmental outcome following preterm birth; Diet and Nutrition - Other diet and nutrition disorders; Reproductive Health and Childbirth - Complications of newborn

• Registration Number: ACTRN12612001084875
• Lead Sponsor: Professor Frank Bloomfield

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2012-10-10
• Study Completion: 2021-05-31
• Last Update Posted: 9 August 2022

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 434

Inclusion Criteria

Babies <1,000 g at birth and admitted to NICU with a UAC placed.

Exclusion Criteria

Birth weight greater than or equal to 1000 g; admission to NICU >24 hours after birth; multiple birth >2 children; congenital disorder affecting growth; inborn error of metabolism; in danger of imminent death.

Study & Design

• Study Type: Interventional
• Study Design: Not specified